PROVIDER PROFILE · NPI 1700935103

Teresa GrossiN.P.

PRACTICEADVANCED DERMATOLOGY & COSMETICS LASER CARE A MEDICAL CORPORATIONSee all providers at this practice →

Nurse PractitionerValencia, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,434

Unique beneficiaries

—

Total services

3,541

Distinct HCPCS

Medicare payment

$119K

Peer benchmark

Total Medicare services vs. 8,685 Nurse Practitioner providers in CA — top quintile (cohort median 222).

PRESCRIBING · PART D · 2024

Total Rx claims

637

Beneficiaries

—

Total drug cost

$116K

Distinct drugs

Brand share

14.9%

Top prescribed drugs

Mometasone Furoate126 claims

Fluorouracil60 claims

Fluocinonide50 claims

Mupirocin50 claims

Triamcinolone Acetonide48 claims

QUALITY · MIPS · 2024

Final MIPS score

91.5

Quality

0.0

Cost

0.0

Improvement activities

40.0

Promoting interop.

90.0

Payment adjustment

0.69%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$996

Payment records

By payment type

Food and Beverage$996

REFERRAL NETWORK

Where Teresa Grossi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Bernard Raskin Dermatology · Valencia, CA	50	279
Aesthetic Surgery & Laser Medical Center Inc Ambulatory Surgical Center · Valencia, CA	17	22
Unilab Corporation Clinical Laboratory · West Hills, CA	14	40

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history